Speaker illustration

Doctor Daniel Oder

University Hospital Würzburg, Würzburg (Germany)

Role of sudden cardiac death as end-stage complication in Fabry disease cardiomyopathy: Impact of primary and secondary prophylactic ICD therapy on long-term outcome

Event: ESC Congress 2017

Topic: Sudden death / resuscitation

Session: Sudden cardiac death

Thumbnail

Role of serum biomarkers for monitoring disease progression in the cardio-specific alpha-galactosidase A genotype N215S

Event: ESC Congress 2017

Topic: Cardiomyopathies

Session: Cardiomyopathy in Fabry disease

Thumbnail

Hereditary cardiomyopathies: The N215S genotype in the alpha galactosidase A gene as an underestimated differential diagnosis of isolated left-ventricular hypertrophy

Event: ESC Congress 2016

Topic: Cardiomyopathies

Session: Prognosis in cardiomyopathies

Thumbnail

Role of implantable cardioverter defibrillator device therapy in patients with progressive Fabry disease

Event: ESC Congress 2016

Topic: Genetic aspects of arrhythmias

Session: Gene and arrhythmias

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb